Skip to results
Modify your search
NARROW
1-20 of 49
Authors: Natacha Entz-Werle
Journal Article
Nanopore sequencing as a cutting-edge technology for medulloblastoma classification Get access
Neuro-Oncology, noae279, https://doi.org/10.1093/neuonc/noae279
Published: 28 December 2024
Journal Article
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors Get access
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2102–2112, https://doi.org/10.1093/neuonc/noae122
Published: 02 August 2024
Journal Article
HGG-17. DECIPHERING GENETICS AND EPIGENETICS OF HIGH-GRADE GLIOMAS WITH BRAF ACTIVATING ALTERATION IS SUPPORTING THE DISCOVERY OF A NEW INTRACRANIAL SARCOMA-LIKE BRAF POSITIVE ENTITY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.301
Published: 18 June 2024
Journal Article
STEM-05. CREATING PATIENT-DERIVED TUMOROIDS TO INVESTIGATE RADIORESISTANCE IN PEDIATRIC BRAIN TUMORS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.776
Published: 18 June 2024
Journal Article
MDB-24. SHH MEDULLOBLASTOMA WITH SMO MUTATION BEFORE THE AGE OF 5YEARS OLD
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.473
Published: 18 June 2024
Journal Article
STEM-04. BIOBANKING PATIENT-DERIVED MODELS OFFERS A PRECISE SPATIAL AND EPIGENETIC APPROACH TO UNRAVEL THE INITIATION, PROGRESSION, AND THERAPEUTIC RESISTANCE OF PEDIATRIC BRAIN TUMORS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.775
Published: 18 June 2024
Journal Article
MODL-05. UNDERSTANDING THE METABOLIC VULNERABILITIES IN INFILTRATING GLIOMATOSIS CEREBRI CELLS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.749
Published: 18 June 2024
Journal Article
MDB-12. NANOPORE SEQUENCING AS A CUTTING-EDGE TECHNOLOGY FOR MEDULLOBLASTOMA CLASSIFICATION
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.461
Published: 18 June 2024
Journal Article
NFS-02. MEDULLOBLASTOMAS WITH ELP1 PATHOGENIC VARIANTS: A WEAKLY PENETRANT SYNDROME WITH A RESTRICTED SPECTRUM IN A LIMITED AGE WINDOW
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.560
Published: 18 June 2024
Journal Article
Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age window
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae075, https://doi.org/10.1093/noajnl/vdae075
Published: 15 May 2024
Journal Article
EDITOR'S CHOICE
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1357–1366, https://doi.org/10.1093/neuonc/noae074
Published: 14 May 2024
Journal Article
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1723–1737, https://doi.org/10.1093/neuonc/noae080
Published: 08 May 2024
Journal Article
MODL-22. DEVELOPMENT OF A PATIENT-DERIVED MODEL BIOBANK TO PROVIDE AN ACCURATE TOOL DECIPHERING BRAIN TUMOR INITIATION, PROGRESSION, AND THERAPEUTIC RESISTANCE
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v303, https://doi.org/10.1093/neuonc/noad179.1173
Published: 10 November 2023
Journal Article
DIPG-33. P16 IMMUNOHISTOCHEMICAL EXPRESSION AS A SURROGATE ASSESSMENT OF CDKN2A ALTERATION IN GLIOMAS LEADING TO PROGNOSTIC SIGNIFICANCES
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i20, https://doi.org/10.1093/neuonc/noad073.080
Published: 12 June 2023
Journal Article
DIPG-31. HIF-1A AND HIF-2A COMBINATORIAL TARGETING OR HOW TO REVERSE THEIR BALANCED ONCOGENIC IMPACT
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i20, https://doi.org/10.1093/neuonc/noad073.078
Published: 12 June 2023
Journal Article
HGG-09. GLIOMATOSIS CEREBRI IN CHILDREN: A POOR PROGNOSTIC, HIGHLY INFILTRATIVE PHENOTYPE OF DIFFUSE PEDIATRIC HIGH-GRADE GLIOMAS WITH DISTINCT MOLECULAR FEATURES
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i40–i41, https://doi.org/10.1093/neuonc/noad073.158
Published: 12 June 2023
Journal Article
DIPG-30. HIF2 OVEREXPRESSION DICTATES AGGRESSIVENESS ADDITIONALLY TO TP53 MUTATIONS IN H3.3K27M PEDIATRIC HIGH-GRADE GLIOMAS THROUGH RAS-MAPK AND WNT/BCATENIN PATHWAYS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i19–i20, https://doi.org/10.1093/neuonc/noad073.077
Published: 12 June 2023
Journal Article
LGG-16. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i91, https://doi.org/10.1093/neuonc/noac079.331
Published: 03 June 2022
Journal Article
HGG-49. Gliomatosis cerebri in children: A collaborative report from the European Society for Pediatric Oncology (SIOPE)
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i72–i73, https://doi.org/10.1093/neuonc/noac079.264
Published: 03 June 2022
Journal Article
HGG-52. Combinatorial modulation of hypoxic pathways leads to anti-tumoral effects in H3.3 K27M midline gliomas
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i73, https://doi.org/10.1093/neuonc/noac079.267
Published: 03 June 2022
